Back

The long journey of individualizing antiplatelet therapy after acute coronary syndromes

European Heart Journal

20 October 2020
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes PREVENTIVE CARDIOLOGY Risk Factors and Prevention BASIC SCIENCE BASICS Pharmacology and Pharmacotherapy

Contributors

Robert F Storey
Robert F Storey

Author

University of Sheffield Sheffield , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Presentation
Antiplatelet strategies
26 March 2023
thumbnail
Congress Presentation
Feasibility and outcomes of tailored antiplatelet therapy at a safety-net hospital
21 March 2026
thumbnail
Congress Presentation
Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3
1 September 2025
thumbnail
Congress Presentation
Antiplatelet therapy prescription patterns for acute coronary syndrome: a decade analysed
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources